54 922 (Granisetron 1 mg)
Pill imprint 54 922 has been identified as Granisetron hydrochloride 1 mg.
Granisetron is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Granisetron 1 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 54 922
- Strength:
- 1 mg
- Color:
- White
- Size:
- 1.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Roxane Laboratories, Inc.
- National Drug Code (NDC):
- 00054-0143
- Inactive Ingredients:
- hypromelloses
lactose
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
More about granisetron
Consumer resources
- Granisetron
- Granisetron solution
- Granisetron tablets
- Granisetron transdermal
- Granisetron Oral, Intravenous (Advanced Reading)
- Granisetron Transdermal (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
